Cost of revenue increased 28.1%
Cost of revenue changed +28.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cost of revenue changed +28.1% from the comparable as-filed period.
SBC / revenue changed +709 basis points from the comparable as-filed period.
Free-cash-flow margin changed +4660 basis points from the comparable as-filed period.
Operating cash-flow margin changed +3136 basis points from the comparable as-filed period.
Shares outstanding changed +15.8% from the comparable as-filed period.
Working capital / assets changed -1952 basis points from the comparable as-filed period.
Current ratio changed -31.5% from the comparable as-filed period.
R&D / revenue changed +129 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed -5.5% from the comparable as-filed period.
Current assets changed +2.5% from the comparable as-filed period.
Capital expenditure changed +2.1% from the comparable as-filed period.
Shares outstanding changed +13.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.